I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Paul Segal Biography and Net Worth

Major Shareholder of Alphatec

Currently, Paul Segal is Chief Executive Officer at LS Power Equity Advisors LLC and Chief Executive Officer of LS Power Development LLC (New York).

In his past career Mr. Segal held the position of President for Luminus Management LLC and Principal at Smith Barney, Inc.

Mr. Segal received an undergraduate degree from Rutgers University School of Engineering.

What is Paul Segal's net worth?: The estimated net worth of Paul Segal is at least $1.01 million as of June 12th, 2023. Mr. Segal owns 100,000 shares of Alphatec stock worth more than $1,006,000 as of November 23rd. This net worth evaluation does not reflect any other assets that Mr. Segal may own. Learn More about Paul Segal's net worth.
How do I contact Paul Segal?: The corporate mailing address for Mr. Segal and other Alphatec executives is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. Alphatec can also be reached via phone at (760) 431-9286 and via email at [email protected]. Learn More on Paul Segal's contact information.
Has Paul Segal been buying or selling shares of Alphatec?: Paul Segal has not been actively trading shares of Alphatec over the course of the past ninety days. Most recently, Paul Segal sold 71,329 shares of the business's stock in a transaction on Monday, June 12th. The shares were sold at an average price of $15.15, for a transaction totalling $1,080,634.35. Following the completion of the sale, the director now directly owns 100,000 shares of the company's stock, valued at $1,515,000. Learn More on Paul Segal's trading history.
Who are Alphatec's active insiders?: Alphatec's insider roster includes Evan Bakst (Director), Jeffrey Black (CFO), Jason Hochberg (Director), Craig Hunsaker (EVP), Scott Lish (SVP), Patrick Miles (CEO), David Mowry (Director), David Pelizzon (Director), Jennifer Pritzker (Major Shareholder), Paul Segal (Major Shareholder), David Sponsel (EVP), and James Tullis (Director). Learn More on Alphatec's active insiders.
Are insiders buying or selling shares of Alphatec?: In the last twelve months, Alphatec insiders bought shares 3 times. They purchased a total of 85,000 shares worth more than $743,050.00. In the last twelve months, insiders at the medical technology company sold shares 12 times. They sold a total of 340,301 shares worth more than $4,593,019.43. The most recent insider tranaction occured on August, 21st when Director David M Demski bought 50,000 shares worth more than $283,500.00. Insiders at Alphatec own 22.8% of the company. Learn More about insider trades at Alphatec.
Information on this page was last updated on 8/21/2024.

Paul Segal Insider Trading History at Alphatec

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/12/2023	Sell	71,329	$15.15	$1,080,634.35	100,000
6/14/2022	Buy	50,000	$6.95	$347,500.00	288,825
6/10/2022	Buy	200	$7.10	$1,420.00	238,825
11/23/2021	Buy	67,496	$10.09	$681,034.64

Paul Segal Buying and Selling Activity at Alphatec

Alphatec Company Overview

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Today's Range

Now: $10.06

$9.97

$10.32

50 Day Range

MA: $6.62

$4.98

$10.20

2 Week Range

Now: $10.06

$4.88

$17.34

Volume

1,122,083 shs

Average Volume

1,959,903 shs

Market Capitalization

$1.43 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

I was wrong. Dead wrong.

From Porter & Company | Ad